IBM To Rally Around 14%? Here Are 10 Top Analyst Forecasts For Monday

Top Wall Street analysts changed their outlook on these top names.

For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Wells Fargo cut the price target for Uber Technologies Inc (NYSE: UBER ) from $102 to $100.

Wells Fargo analyst Ken Gawrelski maintained an Overweight rating.

Uber shares closed at $74.43 on Thursday.

See how other analysts view this stock.

Barclays raised Lincoln National Corp (NYSE: LNC ) price target from $42 to $45.

Barclays analyst Alex Scott upgraded the stock from Equal-Weight to Overweight.

Lincoln National shares closed at $37.00 on Thursday.

See how other analysts view this stock.

Baird cut price target for Adapthealth Corp (NASDAQ: AHCO ) from $18 to $15.

Baird analyst Eric Coldwell maintained an Outperform rating.

Adapthealth shares closed at $10.76 on Thursday.

See how other analysts view this stock.

B of A Securities raised the price target for IBM (NYSE: IBM ) from $315 to $330.

B of A Securities analyst Wamsi Mohan maintained a Buy rating.

IBM shares closed at $289.52 on Thursday.

See how other analysts view this stock.

HSBC increased Progressive Corp (NYSE: PGR ) price target from $214 to $221.

HSBC analyst Vikram Gandhi maintained a Hold rating.

Progressive shares closed at $232.22 on Thursday.

See how other analysts view this stock.

Bernstein raised Datadog Inc (NASDAQ: DDOG ) price target from $180 to $226.

Bernstein analyst Peter Weed downgraded the stock from Outperform to Market Perform.

Datadog shares closed at $260.36 on Thursday.

See how other analysts view this stock.

Raymond James boosted Delta Air Lines Inc (NYSE: DAL ) price target from $80 to $104.

Raymond James analyst Savanthi Syth downgraded the stock from Strong Buy to Outperform.

Delta Air shares closed at $92.75 on Thursday.

See how other analysts view this stock.

Goldman Sachs raised the price target for Murphy USA Inc (NYSE: MUSA ) from $380 to $550.

Goldman Sachs analyst Bonnie Herzog upgraded the stock from Sell to Neutral.

Murphy USA shares closed at $560.75 on Thursday.

See how other analysts view this stock.

Roth Capital increased Nuvectis Pharma Inc (NASDAQ: NVCT ) price target from $20 to $33.

Roth Capital analyst Jonathan Aschoff maintained a Buy rating.